ChromaDex Corp. (CDXC)

[jfk]

I wouldn't count on Blue Skys any time soon. CDXC explained that Taiwan is their next target, and that no approval to sell product is expected until later in 2019, which means no product sales until 2020. What other rabbits do they have that can be pulled out of the hat? Beats me.. I am disappointed in the lack of transparency in terms of whether the product is truly succeeding, ie. being re-purchased, the way it needs to be in the Asian markets in order to continue to be stocked at retail. LiKaShing will give TruNiagen a little breathing room, but if its a dog at retail, it won't stay in the stores, and it won't be given space in new markets either. I think we may be at a standstill here. Waiting for the next Rabbit. I hope Fried is a magician..